• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Non-Markov multistate modeling using time-varying covariates, with application to progression of liver fibrosis due to hepatitis C following liver transplant.使用时变协变量的非马尔可夫多状态建模及其在肝移植后丙型肝炎所致肝纤维化进展中的应用
Int J Biostat. 2010 Feb 20;6(1):Article 7. doi: 10.2202/1557-4679.1213.
2
Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis.未经治疗的丙型肝炎感染患者肝纤维化的活检进展:非马尔可夫多状态模型分析。
PLoS One. 2011;6(5):e20104. doi: 10.1371/journal.pone.0020104. Epub 2011 May 27.
3
Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model.使用马尔可夫模型对慢性丙型肝炎患者的纤维化进展进行量化。
J Viral Hepat. 2002 Mar;9(2):114-22. doi: 10.1046/j.1365-2893.2002.00340.x.
4
The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.活体供肝肝移植与尸体供肝肝移植后丙型肝炎复发的纤维化进展差异归因于供体年龄的差异。
Liver Transpl. 2008 Dec;14(12):1778-86. doi: 10.1002/lt.21598.
5
Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C.丙型肝炎复发的肝移植患者和非移植慢性丙型肝炎患者的肝星状细胞激活。
Liver Transpl. 2007 Jul;13(7):1017-27. doi: 10.1002/lt.21178.
6
Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C.确定用于预测丙型肝炎肝移植后早期肝硬化的快速纤维化的最佳指标。
Transpl Infect Dis. 2013 Dec;15(6):588-99. doi: 10.1111/tid.12134. Epub 2013 Sep 13.
7
Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.肝移植受者的丙型肝炎病毒治疗:反应预测指标、对纤维化进展的影响以及纤维化初始阶段的重要性
Liver Transpl. 2008 Dec;14(12):1766-77. doi: 10.1002/lt.21635.
8
Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.杀伤细胞免疫球蛋白样受体基因型及杀伤细胞免疫球蛋白样受体-人类白细胞抗原C配体兼容性影响肝移植后丙型肝炎病毒复发的严重程度。
Liver Transpl. 2009 Apr;15(4):390-9. doi: 10.1002/lt.21673.
9
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up.稳定型丙型肝炎病毒肝移植患者免疫抑制方案的 Tor Vergata 撤药:10 年随访。
Transpl Int. 2013 Mar;26(3):259-66. doi: 10.1111/tri.12023. Epub 2012 Dec 20.
10
Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C.丙型肝炎移植后供肝年龄增长与纤维化快速进展
Gut. 2002 Aug;51(2):248-52. doi: 10.1136/gut.51.2.248.

引用本文的文献

1
A discrete-time split-state framework for multi-state modeling with application to describing the course of heart disease.一种用于多状态建模的离散时间分裂状态框架及其在描述心脏病病程中的应用。
BMC Med Res Methodol. 2025 Feb 28;25(1):54. doi: 10.1186/s12874-025-02512-6.
2
Hepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and Management.肝移植后丙型肝炎复发:机制与管理。
J Clin Transl Hepatol. 2014 Sep;2(3):189-96. doi: 10.14218/JCTH.2014.00016. Epub 2014 Sep 15.
3
Recurrence of hepatitis C after liver transplantation.肝移植后丙型肝炎复发。
Ann Gastroenterol. 2013;26(4):304-313.
4
Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis.未经治疗的丙型肝炎感染患者肝纤维化的活检进展:非马尔可夫多状态模型分析。
PLoS One. 2011;6(5):e20104. doi: 10.1371/journal.pone.0020104. Epub 2011 May 27.

本文引用的文献

1
Estimating complex multi-state misclassification rates for biopsy-measured liver fibrosis in patients with hepatitis C.估计丙型肝炎患者经活检测量的肝纤维化的复杂多状态错误分类率。
Int J Biostat. 2009;5(1):Article 5. doi: 10.2202/1557-4679.1139.
2
Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C.非裔美国人和高加索裔美国人慢性丙型肝炎患者的纤维化进展情况。
Clin Gastroenterol Hepatol. 2008 Dec;6(12):1403-11. doi: 10.1016/j.cgh.2008.08.006. Epub 2008 Aug 19.
3
Exceeding the limits of liver histology markers.超出肝脏组织学标志物的限度。
J Hepatol. 2009 Jan;50(1):36-41. doi: 10.1016/j.jhep.2008.07.039. Epub 2008 Oct 18.
4
Diagnosis and quantitation of fibrosis.纤维化的诊断与定量分析。
Gastroenterology. 2008 May;134(6):1670-81. doi: 10.1053/j.gastro.2008.03.001.
5
Non-invasive markers for the prediction of fibrosis in chronic hepatitis C infection.用于预测慢性丙型肝炎感染中纤维化的非侵入性标志物。
Hepatol Res. 2008 Aug;38(8):762-9. doi: 10.1111/j.1872-034X.2008.00364.x. Epub 2008 May 7.
6
A semiparametric transition model with latent traits for longitudinal multistate data.用于纵向多状态数据的具有潜在特征的半参数转换模型。
Biometrics. 2008 Dec;64(4):1032-42. doi: 10.1111/j.1541-0420.2008.01011.x. Epub 2008 Mar 19.
7
Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression.根据报告的风险因素病史估算过去丙型肝炎感染风险:对推算感染年龄和纤维化进展建模的意义。
BMC Infect Dis. 2007 Dec 10;7:145. doi: 10.1186/1471-2334-7-145.
8
Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model.使用马尔可夫模型对慢性丙型肝炎患者的纤维化进展进行量化。
J Viral Hepat. 2002 Mar;9(2):114-22. doi: 10.1046/j.1365-2893.2002.00340.x.
9
Hidden Markov models for the onset and progression of bronchiolitis obliterans syndrome in lung transplant recipients.肺移植受者闭塞性细支气管炎综合征发病和进展的隐马尔可夫模型
Stat Med. 2002 Jan 15;21(1):113-28. doi: 10.1002/sim.886.
10
HCV-related fibrosis progression following liver transplantation: increase in recent years.
J Hepatol. 2000 Apr;32(4):673-84. doi: 10.1016/s0168-8278(00)80231-7.

使用时变协变量的非马尔可夫多状态建模及其在肝移植后丙型肝炎所致肝纤维化进展中的应用

Non-Markov multistate modeling using time-varying covariates, with application to progression of liver fibrosis due to hepatitis C following liver transplant.

作者信息

Bacchetti Peter, Boylan Ross D, Terrault Norah A, Monto Alexander, Berenguer Marina

机构信息

University of California, San Francisco, CA, USA.

出版信息

Int J Biostat. 2010 Feb 20;6(1):Article 7. doi: 10.2202/1557-4679.1213.

DOI:10.2202/1557-4679.1213
PMID:20305705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2836212/
Abstract

Multistate modeling methods are well-suited for analysis of some chronic diseases that move through distinct stages. The memoryless or Markov assumptions typically made, however, may be suspect for some diseases, such as hepatitis C, where there is interest in whether prognosis depends on history. This paper describes methods for multistate modeling where transition risk can depend on any property of past progression history, including time spent in the current stage and the time taken to reach the current stage. Analysis of 901 measurements of fibrosis in 401 patients following liver transplantation found decreasing risk of progression as time in the current stage increased, even when controlled for several fixed covariates. Longer time to reach the current stage did not appear associated with lower progression risk. Analysis of simulation scenarios based on the transplant study showed that greater misclassification of fibrosis produced more technical difficulties in fitting the models and poorer estimation of covariate effects than did less misclassification or error-free fibrosis measurement. The higher risk of progression when less time has been spent in the current stage could be due to varying disease activity over time, with recent progression indicating an "active" period and consequent higher risk of further progression.

摘要

多状态建模方法非常适合分析一些经历不同阶段的慢性疾病。然而,通常所做的无记忆或马尔可夫假设对于某些疾病可能存在疑问,比如丙型肝炎,对于这类疾病,人们关注预后是否取决于病史。本文描述了多状态建模方法,其中转移风险可以取决于过去进展史的任何属性,包括在当前阶段所花费的时间以及达到当前阶段所花费的时间。对401例肝移植患者的901次纤维化测量进行分析发现,即使在控制了几个固定协变量的情况下,随着在当前阶段时间的增加,进展风险也在降低。达到当前阶段的时间较长似乎与较低的进展风险无关。基于移植研究的模拟场景分析表明,与较少的错误分类或无错误的纤维化测量相比,更大程度的纤维化错误分类在模型拟合中产生了更多技术困难,并且协变量效应的估计更差。在当前阶段花费时间较少时进展风险较高可能是由于疾病活动随时间变化,近期进展表明处于“活跃”期,因此进一步进展的风险更高。